Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Evaluating the Efficacy and Safety of Mirikizumab in Adults Over 60 With Moderate to Severe Crohn's Disease and Ulcerative Colitis: A Phase IV Multicenter Interventional Study

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT07059130
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:27:36.710072+00:00
Published At
2025-07-10T00:00:00+00:00
Record Updated At
2025-07-10
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Crohn Disease (CD)", "Crohns Disease", "Ulcerative Colitis (UC)"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-07-10"
protocolSection.identificationModule.nctId
"NCT07059130"
protocolSection.identificationModule.officialTitle
"Evaluating the Efficacy and Safety of Mirikizumab in Adults Over 60 With Moderate to Severe Crohn\u0027s Disease and Ulcerative Colitis: A Phase IV Multicenter Interventional Study"
protocolSection.statusModule.overallStatus
"NOT_YET_RECRUITING"
protocolSection.designModule.phases
["PHASE4"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Crohn Disease (CD) (protocolSection.conditionsModule.conditions)
  • Crohns Disease (protocolSection.conditionsModule.conditions)
  • Ulcerative Colitis (UC) (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.